Open study of pranlukast add-on therapy in intractable partial epilepsy
- 31 March 2013
- journal article
- Published by Elsevier BV in Brain & Development
- Vol. 35 (3), 236-244
- https://doi.org/10.1016/j.braindev.2012.04.001
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Pranlukast Attenuates Hydrogen Peroxide–induced Necrosis in Endothelial Cells by Inhibiting Oxygen Reactive Species–mediated Collapse of Mitochondrial Membrane PotentialJournal of Cardiovascular Pharmacology, 2011
- The role of inflammation in epilepsyNature Reviews Neurology, 2010
- Prevention or Modification of Epileptogenesis after Brain Insults: Experimental Approaches and Translational ResearchPharmacological Reviews, 2010
- Pranlukast Attenuates Ischemia-like Injury in Endothelial Cells Via Inhibiting Reactive Oxygen Species Production and Nuclear Factor-κB ActivationJournal of Cardiovascular Pharmacology, 2009
- Glutamate and astrocytes—Key players in human mesial temporal lobe epilepsy?Epilepsia, 2008
- Increased Numbers of Coassembled PSD-95 to NMDA-receptor Subunits NR2B and NR1 in Human Epileptic Cortical DysplasiaEpilepsia, 2004
- PranlukastDrugs, 2003
- Adjunctive therapy with oxcarbazepine in children with partial seizuresNeurology, 2000
- Early Identification of Refractory EpilepsyThe New England Journal of Medicine, 2000
- A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in childrenNeurology, 1999